Differential kinetics of effector and regulatory T cells in patients on calcineurin inhibitor-based drug regimens

Kidney International

Volumn 76, Issue 5, 2009, Pages 557-566

  Presser, Daniela ^a   Sester, Urban ^a   Mohrbach, Janine ^a   Janssen, Martin ^a   Köhler, Hans ^a   Sester, Martina ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Cytomegalovirus; Effector T cells; Immunosuppression; Infectious diseases; Regulatory T cells; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; CYTOKINE; DACLIZUMAB; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3;

ADULT; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CD4+ CD25+ T LYMPHOCYTE; CELL COUNT; CELL KINETICS; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOWN REGULATION; DRUG EFFECT; EFFECTOR CELL; GRAFT RECIPIENT; GRAFT REJECTION; HEMODIALYSIS PATIENT; HUMAN; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; KIDNEY GRAFT; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL DEPLETION;

ADULT; AGED; CALCINEURIN; CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY TRANSPLANTATION; KINETICS; LONGITUDINAL STUDIES; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY;

EID: 68949200877     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.198     Document Type: Article

References (40)

1. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199-210.
2. Lechler RI, Garden OA, Turka LA. The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol 2003; 3: 147-158.
3. Hara M, Kingsley CI, Niimi M et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166: 3789-3796.
4. Wang HY, Wang RF. Regulatory T cells and cancer. Curr Opin Immunol 2007; 19: 217-223.
5. Boettler T, Spangenberg HC, Neumann-Haefelin C et al. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 2005; 79: 7860-7867.
6. Rouse BT, Sarangi PP, Suvas S. Regulatory T cells in virus infections. Immunol Rev 2006; 212: 272-286.
7. Martinez-Llordella M, Puig-Pey I, Orlando G et al. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 2007; 7: 309-319.
8. Louis S, Braudeau C, Giral M et al. Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006; 81: 398-407.
9. Sester M, Sester U, Gärtner B et al. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation 2001; 71: 1287-1294.
10. Sester U, Junker H, Hodapp T et al. Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy. Nephrol Dial Transplant 2006; 21: 3258-3268.
11. Sester M, Sester U, Alarcon Salvador S et al. Age-related decrease in adenovirus-specific T cell responses. J Infect Dis 2002; 185: 1379-1387.
12. Liu W, Putnam AL, Xu-Yu Z et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exper Med 2006; 203: 1701-1711.
13. Sester U, Gärtner BC, Wilkens H et al. Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation. Am J Transplant 2005; 5: 1483-1489.
14. Tkaczuk J, Yu CL, Baksh S et al. Effect of anti-IL-2Ralpha antibody on IL-2-induced Jak/STAT signaling. Am J Transplant 2002; 2: 31-40.
15. Waldmann H, Adams E, Fairchild P et al. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol Rev 2006; 212: 301-313.
16. Waldmann H, Graca L, Adams E et al. Regulatory T cells in transplantation tolerance. Curr Top Microbiol Immunol 2005; 293: 249-264.
17. Toka FN, Suvas S, Rouse BT. CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1. J Virol 2004; 78: 13082-13089.
18. Suvas S, Kumaraguru U, Pack CD et al. CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exper Med 2003; 198: 889-901.
19. D'Cruz LM, Klein L. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol 2005; 6: 1152-1159.
20. Fontenot JD, Rasmussen JP, Gavin MA et al. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005; 6: 1142-1151.
21. Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 2004; 4: 665-674.
22. Suzuki H, Kundig TM, Furlonger C et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 1995; 268: 1472-1476.
23. Malek TR, Yu A, Vincek V et al. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002; 17: 167-178.
24. Zhang H, Chua KS, Guimond M et al. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat Med 2005; 11: 1238-1243.
25. Bram RJ, Hung DT, Martin PK et al. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol Cell Biol 1993; 13: 4760-4769.
26. Baan CC, van der Mast BJ, Klepper M et al. Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells. Transplantation 2005; 80: 110-117.
27. Zeiser R, Nguyen VH, Beilhack A et al. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 2006; 108: 390-399.
28. Mantel PY, Ouaked N, Ruckert B et al. Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol 2006; 176: 3593-3602.
29. Demirkiran A, Hendrikx TK, Baan CC et al. Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting? Transplantation 2008; 85: 783-789.
30. Allan SE, Crome SQ, Crellin NK et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007; 19: 345-354.
31. Wang J, Ioan-Facsinay A, van der Voort EI et al. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 2007; 37: 129-138.
32. San Segundo DS, Ruiz JC, Izquierdo M et al. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients. Transplantation 2006; 82: 550-557.
33. Bloom DD, Chang Z, Fechner JH et al. CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H. Am J Transplant 2008; 8: 793-802.
34. Bluestone JA, Liu W, Yabu JM et al. The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation. Am J Transplant 2008; 8: 2086-2096.
35. Kreijveld E, Koenen HJ, Klasen IS et al. Following Anti-CD25 Treatment, A Functional CD4+CD25+ Regulatory T-Cell Pool Is Present in Renal Transplant Recipients. Am J Transplant 2006.
36. Coenen JJ, Koenen HJ, van Rijssen E et al. Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells. Blood 2006; 107: 1018-1023.
37. Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 2005; 105: 4743-4748.
38. Noris M, Casiraghi F, Todeschini M et al. Regulatory T cells and T cell depletion: role of immunosuppressive drugs. J Am Soc Nephrol 2007; 18: 1007-1018.
39. Epple HJ, Loddenkemper C, Kunkel D et al. Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 2006; 108: 3072-3078.
40. Sester U, Presser D, Dirks J et al. PD-1 Expression and IL-2 Loss of Cytomegalovirus- Specific T Cells Correlates with Viremia and Reversible Functional Anergy. Am J Transplant 2008; 8: 1486-1497.